Next Generation Protein Therapeutics & Bioconjugates Summit is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.


Eugene Zhukovsky, Ph.D.
Chief Scientific Officer, Research at Biomunex Pharmaceuticals


Dr. Zhukovsky has over two decades of experience in the biotherapeutics R&D. He applies optimized monospecific and novel bispecific antibody platforms to the development of immunotherapeutics for cancer, with a particular focus on leveraging the biology of immune checkpoint modulators. He is the CSO of Biomunex Pharmaceuticals, and also consults with other biotechnology companies.

Previously, he served as the CSO of Affimed. Prior to that he was a Senior Research Fellow in the Biotherapeutics Department at Boehringer Ingelheim Pharmaceuticals, Inc., and an Associate Director at Xencor, Inc. Dr. Zhukovsky performed a postdoctoral fellowship at Genentech, Inc. He received a PhD in biochemistry from Brandeis University.

Eugene Zhukovsky, Ph.D.'s Network

Agenda Sessions

  • The Development of Innovative Therapeutics for Oncology

    , 3:30pm